Danaher Corporation logo

Danaher Corporation (DHRC)

Market Closed
23 Jun, 11:01
170. 80
+0.84
+0.49%
- Market Cap
28.65 P/E Ratio
1.08% Div Yield
0 Volume
7.58 Eps
169.96
Previous Close
Day Range
170.58 170.8
Year Range
153.52 258.9
Want to track DHRC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 28 days

Summary

DHRC closed today higher at €170.8, an increase of 0.49% from yesterday's close, completing a monthly decrease of -1.95% or €3.4. Over the past 12 months, DHRC stock lost -23.08%.
DHRC pays dividends to its shareholders, with the most recent payment made on Apr 25, 2025. The next announced payment will be in In 1 month on Jul 25, 2025 for a total of €0.32.
The last earnings report, released on Apr 21, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.71%, based on the last three reports. The next scheduled earnings report is due on Jul 21, 2025.
Danaher Corporation has completed 7 stock splits, with the recent split occurring on Oct 02, 2023.
The company's stock is traded on 12 different exchanges and in various currencies, with the primary listing on NYSE (USD).

DHRC Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
Why Danaher (DHR) is a Top Growth Stock for the Long-Term

Why Danaher (DHR) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 3 days ago
Danaher: High Capex And Low Debt Despite Trump Legislation

Danaher: High Capex And Low Debt Despite Trump Legislation

The company has achieved returns on equity above 7.8% since 2019. Additionally, it reduced its liabilities-to-assets ratio to 35.72% this quarter, indicating a low risk of bankruptcy. Danaher expects an excellent growth outlook in the upcoming years, due to the significant investment that the biopharma industry has dedicated to developing new medical therapies. Between 2017 and 2024, Danaher invested 25.81% of its revenues to expand its operations, which has contributed to the growth rate of its revenues.

Seekingalpha | 4 days ago
Danaher Schedules Second Quarter 2025 Earnings Conference Call

Danaher Schedules Second Quarter 2025 Earnings Conference Call

WASHINGTON , June 17, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2025 on Tuesday, July 22, 2025 beginning at 8:00 a.m. ET and lasting approximately one hour.

Prnewswire | 6 days ago

Danaher Corporation Dividends

Danaher Corporation logo
DHR In 4 days
Announced
Quarterly
$0.32 Per Share
Danaher Corporation logo
DHR 2 months ago
Paid
Quarterly
$0.32 Per Share
Danaher Corporation logo
DHR 5 months ago
Paid
Quarterly
$0.27 Per Share
Danaher Corporation logo
DHR 8 months ago
Paid
Quarterly
$0.27 Per Share
Danaher Corporation logo
DHR 11 months ago
Paid
Quarterly
$0.27 Per Share

Danaher Corporation Earnings

21 Jul 2025 (In 4 weeks) Date
-
Cons. EPS
-
EPS
21 Apr 2025 Date
-
Cons. EPS
-
EPS
29 Jan 2025 Date
2.14
Cons. EPS
2.14
EPS
28 Jan 2025 Date
2.14
Cons. EPS
-
EPS
22 Oct 2024 Date
1.57
Cons. EPS
1.71
EPS
Danaher Corporation logo
DHR In 4 days
Announced
Quarterly
$0.32 Per Share
Danaher Corporation logo
DHR 2 months ago
Paid
Quarterly
$0.32 Per Share
Danaher Corporation logo
DHR 5 months ago
Paid
Quarterly
$0.27 Per Share
Danaher Corporation logo
DHR 8 months ago
Paid
Quarterly
$0.27 Per Share
Danaher Corporation logo
DHR 11 months ago
Paid
Quarterly
$0.27 Per Share
21 Jul 2025 (In 4 weeks) Date
-
Cons. EPS
-
EPS
21 Apr 2025 Date
-
Cons. EPS
-
EPS
29 Jan 2025 Date
2.14
Cons. EPS
2.14
EPS
28 Jan 2025 Date
2.14
Cons. EPS
-
EPS
22 Oct 2024 Date
1.57
Cons. EPS
1.71
EPS

Danaher Corporation (DHRC) FAQ

What is the stock price today?

The current price is €170.80.

On which exchange is it traded?

Danaher Corporation is listed on NYSE.

What is its stock symbol?

The ticker symbol is DHRC.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Jul 21, 2025.

Has Danaher Corporation ever had a stock split?

Danaher Corporation had 7 splits and the recent split was on Oct 02, 2023.

Danaher Corporation Profile

Medical - Diagnostics & Research Industry
Healthcare Sector
Mr. Rainer M. Blair CEO
XWBO Exchange
US2358511028 ISIN
US Country
61,000 Employees
28 Mar 2025 Last Dividend
2 Oct 2023 Last Split
5 Jan 1979 IPO Date

Overview

Danaher Corporation is a global powerhouse in the design, manufacturing, and marketing of a vast array of professional, medical, industrial, and commercial products and services. With its inception in 1969 and a significant rebranding in 1984, where it transitioned from Diversified Mortgage Investors, Inc. to Danaher Corporation, the company has established a formidable presence in various sectors. Headquartered in Washington, D.C., Danaher stands out through its commitment to innovation, excellence, and enhancing the quality of life worldwide.

Products and Services

  • Biotechnology: Danaher's biotechnology segment is a provider of bioprocess technologies, consumables, and services enhancing the development and manufacture of therapeutics. This includes cell line and cell culture media development, chromatography resins, filtration technologies, aseptic fill-finish solutions, single-use hardware, and comprehensive services aimed at setting up full manufacturing suites.
  • Life Sciences: This segment delivers a wide range of products including mass spectrometers, flow cytometry, genomics solutions, lab automation instruments, centrifugation, liquid handling automation instruments, antibodies and reagents, particle counting and characterization tools, microscopes, and protein consumables. Among the notable brands under the Life Sciences segment are ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX, each providing specialized products for genomic medicines and industrial filtration.
  • Diagnostics: Danaher’s diagnostics sector offers a comprehensive range of chemistry, immunoassay, microbiology, automation systems, molecular diagnostics, acute care, and pathology diagnostics products. Aimed at hospitals, physicians' offices, reference laboratories, and other critical care settings, this segment ensures the delivery of clinical instruments, reagents, consumables, software, and dedicated services to support critical diagnostics.

Contact Information

Address: 2200 Pennsylvania Avenue, NW
Phone: 202 828 0850